Clinical Trials Browser

Completed × Lymphoma, Large B-Cell, Diffuse × umbralisib × Clear all

NCT02874404 2023-10-05

TGR-1202 and Ibrutinib in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Phase 2 Completed

13 enrolled 10 charts

Lymphoma, Large B-Cell, Diffuse